BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 20302516)

  • 1. Role of N-acetyl-N-nitroso-tryptophan as nitric oxide donor in the modulation of HIF-1-dependent signaling.
    Berchner-Pfannschmidt U; Tug S; Hu J; Reyes BD; Fandrey J; Kirsch M
    Biol Chem; 2010 May; 391(5):533-40. PubMed ID: 20302516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of N-nitrosomelatonin as nitric oxide donor in cell culture experiments.
    Berchner-Pfannschmidt U; Tug S; Trinidad B; Becker M; Oehme F; Flamme I; Fandrey J; Kirsch M
    J Pineal Res; 2008 Nov; 45(4):489-96. PubMed ID: 18673420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury.
    Natarajan R; Salloum FN; Fisher BJ; Kukreja RC; Fowler AA
    Circ Res; 2006 Jan; 98(1):133-40. PubMed ID: 16306444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-hypoxic activation of the negative regulatory feedback loop of prolyl-hydroxylase oxygen sensors.
    Tug S; Delos Reyes B; Fandrey J; Berchner-Pfannschmidt U
    Biochem Biophys Res Commun; 2009 Jul; 384(4):519-23. PubMed ID: 19427832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide inhibits HIF-1alpha protein accumulation under hypoxic conditions: implication of 2-oxoglutarate and iron.
    Kozhukhar AV; Yasinska IM; Sumbayev VV
    Biochimie; 2006 May; 88(5):411-8. PubMed ID: 16310922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
    Hewitson KS; Schofield CJ; Ratcliffe PJ
    Methods Enzymol; 2007; 435():25-42. PubMed ID: 17998047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness.
    Jokilehto T; Rantanen K; Luukkaa M; Heikkinen P; Grenman R; Minn H; Kronqvist P; Jaakkola PM
    Clin Cancer Res; 2006 Feb; 12(4):1080-7. PubMed ID: 16489060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolyl-hydroxylase inhibition and HIF activation in osteoblasts promotes an adipocytic phenotype.
    Irwin R; LaPres JJ; Kinser S; McCabe LR
    J Cell Biochem; 2007 Feb; 100(3):762-72. PubMed ID: 17031858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quercetin activates an angiogenic pathway, hypoxia inducible factor (HIF)-1-vascular endothelial growth factor, by inhibiting HIF-prolyl hydroxylase: a structural analysis of quercetin for inhibiting HIF-prolyl hydroxylase.
    Jeon H; Kim H; Choi D; Kim D; Park SY; Kim YJ; Kim YM; Jung Y
    Mol Pharmacol; 2007 Jun; 71(6):1676-84. PubMed ID: 17377063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors.
    Henze AT; Riedel J; Diem T; Wenner J; Flamme I; Pouyseggur J; Plate KH; Acker T
    Cancer Res; 2010 Jan; 70(1):357-66. PubMed ID: 20028863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the catalytic activity of hypoxia-inducible factor-1alpha-prolyl-hydroxylase 2 by a MYND-type zinc finger.
    Choi KO; Lee T; Lee N; Kim JH; Yang EG; Yoon JM; Kim JH; Lee TG; Park H
    Mol Pharmacol; 2005 Dec; 68(6):1803-9. PubMed ID: 16155211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of prolyl hydroxylase domain proteins promotes therapeutic revascularization.
    Loinard C; Ginouvès A; Vilar J; Cochain C; Zouggari Y; Recalde A; Duriez M; Lévy BI; Pouysségur J; Berra E; Silvestre JS
    Circulation; 2009 Jul; 120(1):50-9. PubMed ID: 19546390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of an oxygen/redox-dependent degradation domain of hypoxia-inducible factor alpha (HIF-alpha) proteins.
    Srinivas V; Zhang LP; Zhu XH; Caro J
    Biochem Biophys Res Commun; 1999 Jul; 260(2):557-61. PubMed ID: 10403805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term effects of pharmacologic HIF stabilization on vasoactive and cytotrophic factors in developing mouse brain.
    Schneider C; Krischke G; Keller S; Walkinshaw G; Arend M; Rascher W; Gassmann M; Trollmann R
    Brain Res; 2009 Jul; 1280():43-51. PubMed ID: 19450570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperoxia attenuates the inhibitory effect of nitric oxide donors on HIF prolyl-4-hydroxylase-2: Implication on discriminative effect of nitric oxide on HIF prolyl-4-hydroxylase-2 and collagen prolyl-4-hydroxylase.
    Yum S; Choi J; Hong S; Park MH; Lee J; Ha NC; Jung Y
    Biochem Pharmacol; 2011 Sep; 82(5):485-90. PubMed ID: 21723853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xanthine oxidase-mediated denitrosation of N-nitroso-tryptophan by superoxide and uric acid.
    Viles K; Mathai C; Jourd'heuil FL; Jourd'heuil D
    Nitric Oxide; 2013 Jan; 28():57-64. PubMed ID: 23099296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redox-sensitivity and site-specificity of S- and N- denitrosation in proteins.
    Jourd'heuil FL; Lowery AM; Melton EM; Mnaimneh S; Bryan NS; Fernandez BO; Park JH; Ha CE; Bhagavan NV; Feelisch M; Jourd'heuil D
    PLoS One; 2010 Dec; 5(12):e14400. PubMed ID: 21203591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Nitrosomelatonin, an efficient nitric oxide donor and transporter in Arabidopsis seedlings.
    Singh N; Jain P; Gupta S; Khurana JM; Bhatla SC
    Nitric Oxide; 2021 Sep; 113-114():50-56. PubMed ID: 34023504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photocontrollable NO-releasing compounds and their biological applications.
    Nakagawa H
    J Clin Biochem Nutr; 2016 Jan; 58(1):2-6. PubMed ID: 26798191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Response of Brain to Chronic Hypoxia and Hyperoxia.
    Terraneo L; Samaja M
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28880206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.